| Record ID | ia:39201016010117 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/39201016010117/39201016010117_marc.xml |
| Download MARC binary | https://www.archive.org/download/39201016010117/39201016010117_meta.mrc |
LEADER: 01812cam a22004330a 4500
001 991105908703706196
008 860731s1986 onc bf eng c
020 $a0662144996 (spiral bdg.)
035 $a(UTL)924049-01utoronto_inst
035 $a(SIRSI)924049$9ExL
035 $a(Sirsi) AIV-9402
035 $a(OCoLC)14757838
035 0 $fhn
040 $aOTU$beng
043 $an-cn---
050 4 $aHD9670.C22$bG69
082 04 $a338.47615
086 14 $aRG48-1/8-1986E
090 8 $aHD 9670 .C22G69 1986$bROBA$c1
090 8 $aHD 9670 .C22G69 1986$bSCAR
100 10 $aGoyer, Robert,$d1927-
245 10 $aRegulatory aspects and their influence on pharmaceutical research and on the introduction of drugs in Canada /$cRobert Goyer.
260 0 $aOttawa :$bCommission of Inquiry on the Pharmaceutical Industry ;$bSupply and Services Canada,$cc1986.
300 $a169 [27] p. ;$c28 cm. --
490 1 $aBackground study / Commission of Inquiry on the Pharmaceutical Industry.
500 $aCCAC no. 192-25172-E-86-05
504 $aIncludes bibliographical references.
596 $a26 52
650 0 $aPharmaceutical industry$zCanada
650 0 $aDrugs$xResearch$zCanada
710 20 $aCanada.$bCommission of Inquiry on the Pharmaceutical Industry.
830 0 $aBackground study (Canada. Commission of Inquiry on the Pharmaceutical Industry)
948 $a07/15/1992$b01/07/2001
965 $a924049
967 \\ $aHathi ETAS
999 $aHD9670 .C22 G69 1986$wLC$c1$i31761011550357$d10/1/2011$e9/1/2011$lSTACKS$mROBARTS$n17$q12$rY$sY$tBOOK$u26/8/1992$yBOOK
999 $aHD9670 .C22 G69 1986$wLC$c1$i39201016010117$d2/4/1998$lREMOTE20$mDOWNSVIEW$n2$q2$rY$sY$tBOOK$u26/8/1992$yBOOK
852 0 $bDOWNSVIEW$cREMOTE20$hHD9670 .C22 G69 1986
852 0 $bROBARTS$cSTACKS$hHD9670 .C22 G69 1986